Rankings
▼
Calendar
IQV
IQVIA Holdings Inc.
$30B
Q4 2020 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$3.3B
+13.9% YoY
Gross Profit
$1.1B
34.1% margin
Operating Income
$289M
8.8% margin
Net Income
$119M
3.6% margin
EPS (Diluted)
$0.62
QoQ Revenue Growth
+18.4%
Cash Flow
Operating Cash Flow
$750M
Free Cash Flow
$574M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$24.6B
Total Liabilities
$18.3B
Stockholders' Equity
$6.0B
Cash & Equivalents
$1.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.3B
$2.9B
+13.9%
Gross Profit
$1.1B
$994M
+13.3%
Operating Income
$289M
$166M
+74.1%
Net Income
$119M
$16M
+643.8%
Revenue Segments
Research And Development Solutions
$1.7B
51%
Technology And Analytics Solutions
$1.4B
43%
Contract Sales And Medical Solutions
$189M
6%
← FY 2020
All Quarters
Q1 2021 →
IQV Q4 2020 Earnings — IQVIA Holdings Inc. Revenue & Financial Results | Market Cap Arena